- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Laurus Labs Limited — Updates, 23-10-2025: Press Release
23-10-2025 | 03:39 pm
23-10-2025 | 03:39 pm
Laurus Labs reports strong H1 results: Revenue up 33% to ₹ 3,223 Cr, EBITDA surged 132% to ₹ 818 Cr (25.4% margins). Growth fueled by CDMO & Generics. Strategic investment in Aarvik Therapeutics for ADC technology and ongoing capacity expansion were key business developments. Interim dividend of ₹0.80/share declared.
No comments yet. Be the first to comment!